Could vitamin c tame anemia? early trial tests high doses in rare blood disorders

NCT ID NCT07612345

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests whether high-dose Vitamin C is safe for people with two rare inherited blood disorders—Pyruvate Kinase Deficiency (PKD) and a form of G6PD deficiency. Both conditions cause red blood cells to break down too quickly, leading to anemia. The study will enroll 3 adults with PKD first, giving them Vitamin C up to three times daily for 3 weeks, while closely monitoring side effects and blood health. If safe, the trial may expand to include more patients and eventually children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLASS A GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Utah

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.